Vancomycin-Associated Leukocytoclastic Vasculitis
Vancomycin is U.S. Food and Drug Administration (FDA) approved for treatment of serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA) or in individuals who have failed, cannot tolerate, or are allergic to other antibiotics. Very few cases of vancomycin-associated leukocytoc...
Saved in:
Main Authors: | Makhawadee Pongruangporn, David J. Ritchie, Dongsi Lu, Jonas Marschall |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2011/356370 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leukocytoclastic Vasculitis in a Patient with Ankylosing Spondylitis
by: Senol Kobak, et al.
Published: (2014-01-01) -
A Case of Leukocytoclastic Vasculitis and Associated Conjunctivitis Following MMR Vaccine Administration
by: Hana I. Nazir, et al.
Published: (2023-01-01) -
Ischemic Retinal Vasculitis Associated with Cataract Surgery and Intracameral Vancomycin
by: Lucas T. Lenci, et al.
Published: (2015-01-01) -
Drug-induced Leukocytoclastic Vasculitis Secondary to Trimethoprim/Sulfamethoxazole: A Case Report
by: Ambika Shivarajpur, et al.
Published: (2025-01-01) -
Hypernephroma Presenting with Cutaneous Leukocytoclastic Vasculitis and Lupus Anticoagulant: Resolution after Nephrectomy
by: Nigel P. Murray, et al.
Published: (2012-01-01)